阿尔夫坦尼尔在儿童群体中的药理动力学
Lorena Medina-Aymerich1, Ngoc Betty Ngo1, Daniel Gonzalez1,2
1Duke Clinical Research Institute, Durham, North Carolina, USA.
Journal of clinical pharmacology
|May 16, 2025
概括
这项研究为儿童开发了阿片类止痛药alfentanil的新剂量建议. 种群药动力学分析提供了一个基于体重的模型,用于优化儿科外科手术过程中的阿尔芬坦尼尔剂量.
科学领域:
- 儿科麻醉学 儿科麻醉学
- 药理动力学 药理动力学
- 药物的剂量 药物的剂量
背景情况:
- 阿尔夫坦尼尔是一种广泛用于儿科手术中的阿片类止痛药和麻醉剂.
- 目前美国食品和药物管理局的标签缺乏针对12岁以下儿童的阿尔芬坦尼尔剂量指南.
- 准确的剂量对于儿科患者的疗效和安全至关重要.
研究的目的:
- 描述阿尔芬坦尼尔在儿科患者中的人口药理动力学.
- 开发一种药理动力学模型,以指导儿童的阿尔芬坦尼尔剂量.
- 在儿科外科设置中建立基于证据的止痛和麻醉剂量方案.
主要方法:
- 使用NONMEM (v7.5) 进行的人口药理动力学分析.
- 包括来自42名静脉注射阿尔芬坦尼尔的儿科患者的58个血度.
- 开发一个包含总体体重 (WT) 的单间模型,以预测清除率 (CL) 和分布量 (V).
主要成果:
- 一个带有第一阶排泄的单间模型最好地描述了阿尔芬坦尼尔的药理动力学.
- 总体体重显著影响了清除 (CL = 7.42 × (WT/70) ^ 0.75) 和分布体积 (V = 12.6 × (WT/70)).
- 包括WT在CL和V的个体间变异性减少了40%以上.
结论:
- 开发的基于体重的药理动力学模型为儿童的阿尔芬坦尼尔剂量提供了基础.
- 模拟表明用于止痛和麻醉的特定玻尿酸和输液方案.
- 建议进行前性评估,以确认拟议的剂量策略的安全性和有效性.
更多相关视频
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
52
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
52
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
45
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
45
Factors Affecting Drug Response: Overview
1.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.7K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
257
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
257
Nonlinear Pharmacokinetics: Overview
214
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
214
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
35
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
35


